Xiao Hua, Shao Xiaofei, Gao Peichun, Zou Hequn, Zhang Xinzhou
Department of Nephrology, Shenzhen People's Hospital (The Second Clinical Medical College of Jinan University, The First Affiliated Hospital of Southern University of Science and Technology), Shenzhen, 518020, People's Republic of China.
Shenzhen Key Laboratory of Kidney Diseases, Shenzhen People's Hospital (The Second Clinical Medical College of Jinan University, The First Affiliated Hospital of Southern University of Science and Technology), Shenzhen, 518055, People's Republic of China.
Diabetes Metab Syndr Obes. 2022 Mar 16;15:839-848. doi: 10.2147/DMSO.S353305. eCollection 2022.
To investigate the correlation between metabolic syndrome components and chronic kidney disease (CKD) among a community population aged 40 years and older in Southern China.
From December 2017 to March 2018, 1969 participants (male n = 715, female n = 1254) aged 40 years and older were recruited in Southern China for a cross-sectional survey. A logistic regression model was established to analyze the correlation between metabolic syndrome components and CKD.
Among the 1969 subjects, 407 (20.7%) were CKD patients, including 152 males (prevalence rate 21.3%) and 255 females (prevalence rate 20.3%). Anthropometric data (waist circumference, age, systolic and diastolic blood pressure), serum/plasma data (serum creatinine, serum uric acid, fasting plasma glucose, C-reactive protein, serum triglyceride), urinary and other findings (body mass index, waist-to-hip and waist-to-height ratios, urinary albumin to creatinine ratio, homeostasis model assessment of insulin resistance) were significantly higher in patients with than without CKD (P < 0.05). Metabolic syndrome and at least some of its components were statistically significant risk factors for CKD in models with and without adjustment for diabetes, obesity and hypertension.
Metabolic syndrome and its single or combined components are independently associated with CKD in community populations aged 40 years and older. The correlation between some components and CKD remained significant in both non-diabetic and non-obese subjects. Correlations between components of metabolic syndrome and CKD show that it is feasible and necessary to carry out targeted screening and intervention tests in people aged 40 and over.
探讨中国南方40岁及以上社区人群中代谢综合征各组分与慢性肾脏病(CKD)之间的相关性。
2017年12月至2018年3月,在中国南方招募了1969名40岁及以上的参与者(男性n = 715,女性n = 1254)进行横断面调查。建立逻辑回归模型以分析代谢综合征各组分与CKD之间的相关性。
在1969名受试者中,407名(20.7%)为CKD患者,其中男性152名(患病率21.3%),女性255名(患病率20.3%)。人体测量数据(腰围、年龄、收缩压和舒张压)、血清/血浆数据(血清肌酐、血清尿酸、空腹血糖、C反应蛋白、血清甘油三酯)、尿液及其他指标(体重指数、腰臀比和腰高比、尿白蛋白肌酐比、胰岛素抵抗稳态模型评估)在CKD患者中显著高于非CKD患者(P < 0.05)。在调整和未调整糖尿病、肥胖和高血压的模型中,代谢综合征及其至少部分组分是CKD的统计学显著危险因素。
代谢综合征及其单一或联合组分与40岁及以上社区人群的CKD独立相关。在非糖尿病和非肥胖受试者中,某些组分与CKD之间的相关性仍然显著。代谢综合征各组分与CKD之间的相关性表明,对40岁及以上人群进行针对性筛查和干预检测是可行且必要的。